Pharma News

Eli Lilly says it has potential to launch 20 new products in 10 years In a presentation to the investment community, Eli Lilly and Company stated it has the potential to launch 20 new products in the 10 years beginning in 2014 and extending through 2023. In addition, Lilly could launch an average of two new indications or line extensions ... Read More »

Govt taking steps to set up funds to promote pharma sector The government is taking a number of initiatives to help pharma firms upgrade technology and promote drug discovery and innovation in the country, Parliament was informed on Friday. The Department of Pharmaceuticals is formulating a Pharmaceutical Technology Upgradation Assistance Scheme to support the pharma industry (medium enterprises only) “to ... Read More »

Indian pharmaceutical market growing at over Rs 2 lakh crore India’s pharmaceutical industry, with a market size of over Rs 2 lakh crore, ranks third in volume and 13th in value across the globe, it was announced on Sunday. “The pharmaceutical industry ranks 3rd in volume and 13th in value across the globe and has a market size of Rs ... Read More »

Sun Pharma joins hands with ICMR for malaria eradication prog  In a first of its kind of public private partnership (PPP), pharmaceutical giant Sun Pharma   has collaborated with the Indian Council of Medical Research (ICMR) to eradicate malaria by 2030. Under this programme, ICMR and Sun Pharma will establish ‘Malaria Free India’ to support the National Framework for Elimination of ... Read More »

Researchers open the way to new treatments for chronic pain and cancer In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length structure of a protein named Transient Receptor Potential Vanilloid subtype 2 (TRPV2). Taken in addition to their study of its molecular mechanism last year, ... Read More »

Sun Pharma gets USFDA nod for eye inflammation drug  Drug major Sun Pharmaceutical Industries   has received approval from the US health regulator for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery. One of the company’s wholly-owned subsidiaries “has received approval from USFDA for its New Drug Application (NDA) related to BromSite ... Read More »

Indorama Ventures acquires BP’s Alabama petrochem complex BANGKOK, THAILAND: Indorama Ventures Public Company Limited (IVL) has acquired the PX, PTA (1,020,000 tonne) and NDC (naphthalene dicarboxylate) assets of BP Amoco Chemical Company (BP) at Decatur, Alabama. The acquisition of the Decatur Paraxylene, PTA and NDC assets coincide with USITC affirmative vote to apply anti subsidy & anti-dumping duties PET resin ... Read More »

Bristol-Myers wins positive CHMP opinion for Opdivo in combination with Yervoy to treat advanced melanoma The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Bristol-Myers Squibb’s Opdivo in combination with Yervoy for the treatment of advanced (unresectable or metastatic) melanoma in adults. The CHMP also added an informative statement to the broad indication that relative ... Read More »

Aurobindo Pharma gets final USFDA nod for gastro reflux drug NEW DELHI: Drug firm Aurobindo PharmaBSE -0.64 % has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the American market. “The company has received final approval from the US Food and Drug Administration (USFDA) to ... Read More »

Increased vitamin C in the diet could help protect against cataracts Higher dietary intake of vitamin C has been found to have a potentially preventative effect on cataract progression in the first twin study of cataracts to examine to what degree genetic and environmental factors influence their progression with age. Cataract is a common condition in which the lens of ... Read More »